J E Kim
Overview
Explore the profile of J E Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
432
Citations
2693
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Riedl J, Fece de la Cruz F, Lin J, Parseghian C, Kim J, Matsubara H, et al.
Ann Oncol
. 2025 Feb;
PMID: 39914665
Background: Mutant-selective inhibitors of KRAS (KRASi) have demonstrated efficacy in KRAS cancers. However, resistance invariably develops, resulting in short-lived responses. We aimed to define the genomic landscape of acquired resistance...
2.
Jang B, Huh K, Yeom H, Kang J, Kim J, Yoon H, et al.
AJNR Am J Neuroradiol
. 2023 Aug;
44(10):1176-1183.
PMID: 37652584
Background And Purpose: Chondrosarcoma and synovial chondromatosis of the temporomandibular joint share overlapping clinical and histopathologic features. We aimed to identify CT and MR imaging features to differentiate chondrosarcoma from...
3.
Hyung J, Lee J, Kim J, Yoon S, Yoo C, Hong Y, et al.
ESMO Open
. 2023 Jun;
8(3):101583.
PMID: 37327700
Background: Human epidermal growth factor receptor 2 (HER2) (ERBB2)-directed agents are standard treatments for patients with HER2-positive breast and gastric cancer. Herein, we report the results of an open-label, single-center,...
4.
Oh C, Kim J, Lee J, Kim S, Kim T, Choi J, et al.
Clin Oncol (R Coll Radiol)
. 2022 Nov;
35(2):e143-e152.
PMID: 36376167
Aims: To evaluate the clinical efficacy of adding temozolomide (TMZ) to preoperative capecitabine (CAP)-based chemoradiotherapy in patients with locally advanced rectal cancer (LARC) and validate O-methylguanine DNA methyltransferase (MGMT) methylation...
5.
Aaltonen T, Amerio S, Amidei D, Anastassov A, Annovi A, Antos J, et al.
Science
. 2022 Apr;
376(6589):170-176.
PMID: 35389814
The mass of the boson, a mediator of the weak force between elementary particles, is tightly constrained by the symmetries of the standard model of particle physics. The Higgs boson...
6.
Kim J, Kim S, Jeon M, Kim J, Kim K, Yun K, et al.
ESMO Open
. 2021 Sep;
6(5):100249.
PMID: 34482181
Background: Patients with advanced sarcomas have a poor prognosis and few treatment options that improve overall survival. We assessed the efficacy and tolerability of pemetrexed and cisplatin combination therapy in...
7.
Woo J, Kim J, Im J, Lee J, Jeong H, Park S, et al.
Mol Psychiatry
. 2021 Jul;
26(12):7853.
PMID: 34305137
No abstract available.
8.
Kim J, Lee H, Paik S, Moon J, Yoon H, Kim S
J Eur Acad Dermatol Venereol
. 2021 Jun;
35(11):e711-e714.
PMID: 34166540
No abstract available.
9.
Jang B, Huh K, Kang J, Kim J, Yi W, Heo M, et al.
Clin Radiol
. 2021 Mar;
76(8):627.e1-627.e11.
PMID: 33762137
Aim: To investigate the imaging features of synovial chondromatosis of the temporomandibular joint (TMJ), which is a rare benign arthropathy with cartilaginous proliferation. Materials And Methods: Computed tomography and magnetic...
10.
Nam S, Yamano A, Kim J, Lim J, Baek S, Kim J, et al.
Int Endod J
. 2021 Feb;
54(7):1142-1154.
PMID: 33641170
Aim: To identify odontogenesis-promoting compounds and examine the molecular mechanism underlying enhanced odontoblast differentiation and tooth formation. Methodology: Five different nymphaeols, nymphaeol B (NB), isonymphaeol B (INB), nymphaeol A (NA),...